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Breast Cancer
The transcription factor forkhead box protein 1 (FOXM1)
drives cell cycle progression and is overexpressed in many
cancers, including breast cancer. Horimoto et al (Am J
Pathol 2011, 179:1148–1156) observed that ER1 expres-
sion suppresses tumor growth and represses FOXM1
mRNA and protein expression in ER but not ER breast
cancer cells, suggesting that ER1 represses ER-depen-
dent FOXM1 transcription. ER1 repressed FOXM1 tran-
scription through an estrogen-response element located
within the proximal promoter region that is also targeted by
ER. The direct binding of ER1 to the FOXM1 promoter
was confirmed by chromatin immunoprecipitation analysis,
which also showed that ectopic expression of ER1 dis-
places ER from the endogenous FOXM1 promoter. Forced
expression of ER1 promoted growth suppression in
MCF-7 cells, but the anti-proliferative effects of ER1 could
be overridden by overexpression of FOXM1. This estrogen-
signaling axis may therefore be important for breast cancer
treatment and prognosis as it could determine responsive-
ness to endocrine therapy.
Tripeptide KdPT Treatment Ameliorates
Intestinal Inflammation
Patients with inflammatory bowel disease (IBD) must often
resort to surgery since disease is frequently refractory to
complete remission. Bettenworth et al (Am J Pathol 2011,
179:1230–1242) investigated whether KdPT, a tripeptide
derivative of the immunomodulatory -melanocyte-stimulat-
ing hormone, could function as an anti-inflammatory small
molecule for treating colitis. KdPT-treated animals showed
greatly reduced severity of inflammation in twomouse colitis
models (dextran sodium sulfate administration and IL-10
gene deficiency). In colonic epithelial cells, KdPT increased
proliferation, accelerated wound closure, and also improved
transepithelial resistance after stimulation with IFN-/TNF-.
KdPTmay act by preventing the loss of tight junction protein
expression and improved barrier function in vivo, thus rep-
resenting a potential new treatment for IBD.
Telomere Length Relates to Alternative Splice
Patterns of Telomerase
Aberrant telomerase expression plays an important role in
tumorigenesis. Wang et al (Am J Pathol 2011, 179:1415–
1420) investigated the relationship between telomere length
and telomerase splice variant expression patterns in benign
andwell-differentiatedmalignant thyroid tumors by studyingsplice variants of full-length telomerase reverse transcrip-
tase (hTERT). Telomere length was inversely correlated with
percentage of full-length hTERT expression rather than with
total amount of hTERT expression. Short telomeres and high
fractions of full-length hTERT transcripts were associated
with follicular and papillary thyroid carcinomas, whereas
long telomeres and low levels of full-length hTERT were
associated with benign thyroid nodules. The correlation be-
tween telomere length and expression of hTERT alternative
splice variants supports the concept that tumors with criti-
cally short telomeres require enzymatically active telome-
rase for continued proliferation and survival.
Role of Angiotensin II in Abdominal Aortic
Aneurysm
Angiotensin II (AngII) can initiate abdominal aortic aneu-
rysm (AAA) development, but whether prolonged AngII ad-
ministration promotes AAA progression is unknown. Rateri
et al (Am J Pathol 2011, 179:1533–1541) infused male
apoE/ mice with AngII, selected mice with AAA, and
treated them for a prolonged period with either saline or
AngII. Saline infusion led to an immediate decrease in sys-
tolic blood pressure with no aneurysmal-related deaths. In
contrast, continuous AngII infusion produced increased sys-
tolic blood pressure, aneurysmal rupture-associated deaths,
increased luminal diameters, and tissue remodeling, with
macrophage infiltration medial to the ruptures. In conclu-
sion, prolonged AngII infusion promotes AAA expansion,
providing a model that may prove useful in testing interven-
tions to slow progression of abdominal aortic aneurysms.
Tumor-Induced Intussusceptive Angiogenesis
Involves Inverse Sprouting
Angiogenesis results either from vessel sprouting or from
intussusceptive angiogenesis in which the pre-existing cap-
illaries divide lengthwise and intraluminal connective tissue
pillars are formed. Paku et al (Am J Pathol 2011, 179:1573–
1585) elucidated the mechanism of pillar formation (inverse
sprouting), observing in tumor vasculature that the nascent
intraluminal pillars contain a collagen bundle covered by
endothelial cells (ECs). Intraluminal endothelial bridges
form and attach to a collagen bundle in the underlying
connective tissue. The actin cytoskeleton of the ECs then
pulls the collagen bundle, transporting the collagen bundle
into and through the vessel lumen. Finally, the pillar matures
through the immigration of connective tissue cells and the
deposition of new collagenous connective tissue. This
mechanism ties the process of endothelial bridging to in-
tussusceptive angiogenesis, providing a new piece to the
puzzle of cancer therapy via angiogenesis inhibition.
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